Based on the data provided, the Blood Grouping Reagents market in the UK shows a steady year-on-year growth in value per capita from 2024 to 2028. The value per capita increases from $1.66 in 2024 to $1.73 in 2028. This indicates a consistent upward trend, reflecting stable market growth over the forecast period. Specifically, the year-on-year percentage increase from 2024 to 2025 is approximately 0.6%, followed by successive increases of around 1.2% each year until 2028. The last observed Compound Annual Growth Rate (CAGR) over the five-year period indicates an average annual growth rate of approximately 1.07%.
Future trends to watch for include potential technological advancements in blood grouping reagents, changing healthcare policies in the UK, and the impact of demographic shifts such as the aging population, which could increase demand for blood grouping. Moreover, any significant changes in the regulatory landscape or emerging competitors could also influence market dynamics.
